Medicine and Dentistry
(3 Iodobenzyl)guanidine
19%
Adolescence
21%
Adverse Event
8%
Body Mass Index
16%
Bone Density
9%
Cancer in Young Adults
20%
Cancer Therapy
10%
Chemotherapy
9%
Childhood Cancer
100%
Cohort Analysis
11%
Craniopharyngioma
20%
Cross Sectional Study
8%
Diabetes Insipidus
6%
Diagnosis
8%
Differentiated Thyroid Cancer
49%
Disease
10%
Endocrine Disease
21%
Endocrinology
9%
Fertility Preservation
14%
Ganglioglioma
7%
Ganglioneuroblastoma
24%
Growth Hormone
7%
Growth Hormone Deficiency
8%
Health Outcomes
11%
Hypothalamus Disease
7%
Hypothyroidism
13%
Intracranial Tumor
22%
Iodine 131
19%
Late Effect
26%
Malignant Neoplasm
23%
Metabolic Syndrome
8%
Multiple Endocrine Neoplasia Type 2b
6%
Neck
8%
Neoplasm
22%
Odds Ratio
7%
Pediatrics
34%
Prevalence
26%
Primary Ovarian Insufficiency
7%
Quality of Life
12%
Radiation Therapy
14%
Radiation Therapy
6%
Radioactive Iodine
7%
Recurrent Disease
11%
Systematic Review
20%
Thyroid Cancer
15%
Thyroid Disease
16%
Thyroid Function
7%
Thyroid Gland
19%
Thyrotropin
9%
Thyroxine
13%
Keyphrases
123I-MIBG
7%
131I-metaiodobenzylguanidine
13%
Adult Cancer
14%
Adult Survivors
8%
Body Mass Index
8%
Cancer Guidelines
14%
Chemotherapy
8%
Childhood Brain Tumor Survivors
12%
Childhood Cancer
34%
Childhood Cancer Survivor Study
11%
Childhood Cancer Survivors
36%
Childhood-onset
6%
Congenital Hypothyroidism
7%
Consensus Statement
9%
Craniopharyngioma
17%
Differentiated Thyroid Cancer
16%
Differentiated Thyroid Carcinoma
29%
Dutch
27%
Endocrine Disorders
16%
Endocrinology
9%
European Society
7%
Fertility Preservation
11%
Health Outcomes
7%
Hypothalamic Dysfunction
8%
Hypothalamic Obesity
18%
Hypothalamic-pituitary Axis
14%
Hypothalamic-pituitary Dysfunction
10%
Hypothyroidism
8%
International Consensus
11%
Late Effects
18%
Long-term Survivors
10%
Multiple Endocrine Neoplasia Type 2 (MEN2)
9%
Netherlands
8%
Neuroblastoma
22%
Pediatric Thyroid Carcinoma
17%
Pituitary Dysfunction
9%
Project Research
9%
Quality of Life
7%
Quality of Survival
12%
Radiotherapy
13%
Risk Factors
22%
Strategic Research
6%
Survivors
46%
Thyroid Cancer
9%
Thyroid Dysfunction
14%
Thyroid Function
8%
Thyroid Gland
13%
Thyroid Hormones
8%
Thyroxine
8%
Working Diagnosis
11%